4
Orphan Designations
0
FDA Approvals
10
Rare Diseases
0
News Articles
| Disease | Drug(s) | Designation | Approved |
|---|---|---|---|
| alveolar soft part sarcoma | CT-2584 Mesylate | Orphan Designation | - |
| carbon monoxide-induced delayed encephalopathy | Lisofylline | Orphan Designation | - |
| clear cell sarcoma | CT-2584 Mesylate | Orphan Designation | - |
| congenital anomalies of kidney and urinary tract 3 | Lisofylline | Orphan Designation | - |
| hormone receptor-positive breast cancer | 1-(11-dodecylamino-10-hydroxyundecyl)-3,7-dimethylxanthine hydrogen methanesulfonate | Orphan Designation | - |
| hormone-resistant breast carcinoma | 1-(11-dodecylamino-10-hydroxyundecyl)-3,7-dimethylxanthine hydrogen methanesulfonate | Orphan Designation | - |
| hormone-resistant prostate carcinoma | 1-(11-dodecylamino-10-hydroxyundecyl)-3,7-dimethylxanthine hydrogen methanesulfonate | Orphan Designation | - |
| malignant mesothelioma | CT-2584 mesylate | Orphan Designation | - |
| neuroacanthocytosis | Lisofylline | Orphan Designation | - |
| undifferentiated pleomorphic sarcoma | CT-2584 Mesylate | Orphan Designation | - |